Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Certolizumab Pegol, Atc L04ab05 For The Period 01.08.2025 31.07.2027 2025-12-13
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Medicines With The Active Ingredient Iron (iii) Derisomalosis (atccode 2025-12-13
Germany Completion Of A Non -exclusive Discount Contract According To § 130a Para. 8 Sgb V To Drugs With The Active Ingredient Rituximab, Except Recipes (l01fa01). 2025-12-13
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Melatonin (exclusively 1mg And 5mg), Atc N05ch01 For The Period 01.08.2025 31.07.2027 2025-12-13
Germany Open House Pharmaceutical Department Treaties Tolvaptan, Except Medicines With Uniform Effects, Atc G04bx21 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Certolizumab Pegol, Atc L04ab05 For The Period 01.08.2025 - 31.07.2027 2025-12-13
Germany Open House Pharmaceutical Department Treaties Erythropoietin Zeta, Atc B03ax01 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Tralokinumab, Atc D11ah07 For The Period 01.08.2025 - 31.07.2027 2025-12-13
Germany Open House Medicinal Practice Treaties Tofacitinib, Atc L04af01 2025-12-13
Germany Open House Pharmaceutical Dact Treaties Brinzolamid And Brimonidin, Atc S01ec24 2025-12-13
Whats app